CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment [Phase 4]
Summary
Phase 4 clinical trial update examining the effect of linagliptin on active GLP-1 concentrations in subjects with renal impairment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED